New Jersey-based generics company Par Pharmaceuticals has acquired Ethics Bio Lab, a contract research organization in Chennai offering bioavailability and bioequivalence study and clinical end point study services to the pharmaceutical and biotechnology industry.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.